Vimian Group AB (publ) has signed an agreement to acquire AllAccem Inc., a leading provider of a veterinary dental sealant product in the US. AllAccem Inc. had revenues of around USD 9 million for the twelve months ending April 2025, and an EBITDA margin significantly above the Vimian Group average.

Founded in 2005 by Jeffery Whiteford (PhD, Chemistry), AllAccem Inc. offers a dental sealant to help prevent plaque and tartar, a leading cause of periodontal disease among companion animals. The company’s main product is SANOS®, a dental sealant sold to veterinary clinics primarily across the United States. SANOS® is included as part of the standard treatment protocol at many veterinary clinics and is a professionally applied barrier-forming coating that has received the seal of acceptance from the Veterinary Oral Health Council (VOHC). The product is applied by veterinarians, after dental cleaning, to the gingival margin to prevent plaque from reattaching to the gumline. In addition to the dental sealant, the company also offers barrier coating products to help and aid in the management of ear infections and wounds. The proprietary formulations are produced in the company’s manufacturing facility in California, US.

“The acquisition of AllAccem is in line with our strategy to expand and strengthen our veterinary dental offering that targets a fast-growing niche in animal health with many untreated animals. AllAccem is a category leader in its field and a high growth, high margin business that has delivered strong double-digit growth over the past years. We are excited to include this clinically proven and well-reputed product in our dental portfolio and leverage our global scale to further accelerate growth and improve dental health among companion animals around the globe”, says Patrik Eriksson, CEO Vimian Group.

AllAccem will become part of Vimian’s MedTech segment and Jeffery Whiteford, founder and CEO of AllAccem Inc., will continue to lead the integrated business.

“We are very pleased to join the Vimian family and could not have found a better partner on our important mission to improve companion animal health globally. Dental health issues are common among companion animals and 80 per cent of all dogs show signs of oral disease by the age of three. As part of Vimian, we can accelerate and strengthen our support to the veterinary community in delivering high-quality veterinary care”, says Jeffery Whiteford, founder and CEO of AllAccem Inc.

The acquisition of AllAccem Inc. is expected to be completed on or around 13 June and is financed with available funds. The acquisition is expected to have marginal impact on earnings per share in the current financial year.

For further information, please contact:

Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability
maria.tullberg@vimian.com
+46 73 626 88 86

About Vimian

Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market’s most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.

Attachments

Vimian Group expands its veterinary dental offering through the acquisition of a leading provider of a dental sealant product

Läs mer på MFN